FDA Approves BAGUERA® C Cervical Disc for One- and Two-Level Disc Replacement

Spineart has received FDA approval for the BAGUERA® C cervical disc for one- and two-level treatment of cervical disc disease, expanding the motion-preserving options available to appropriately selected patients in the United States. Backed by nearly two decades of international clinical experience, randomized U.S. trials, and long-term data demonstrating preserved motion, the approval marks an important advancement in cervical disc replacement technology.